Evidence map›Paper›PMID 27398807›Full record

ArticlePLoS genetics2016

Functional Crosstalk between the PP2A and SUMO Pathways Revealed by Analysis of STUbL Suppressor, razor 1-1.

Minghua Nie, Emily Arner, John Prudden, Lana Schaffer, Steven Head, Michael N Boddy

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Minghua NieDepartment of Cell and Molecular Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Emily ArnerDepartment of Cell and Molecular Biology, The Scripps Research Institute, La Jolla, California, United States of America.ORCID 0000-0003-2394-8681
John PruddenDepartment of Cell and Molecular Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Lana SchafferMicroarray and Next Generation Sequencing Core Facility, The Scripps Research Institute, La Jolla, California, United States of America.
Steven HeadMicroarray and Next Generation Sequencing Core Facility, The Scripps Research Institute, La Jolla, California, United States of America.
Michael N BoddyDepartment of Cell and Molecular Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Scripps Research Institute · US

Funding

Studies of the Rad60-Smc5-Smc6 DNA Repair ComplexR01GM068608 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI BODDY, MICHAEL N · 2003 to 2020
$6.2M
SUMO-dependent Regulation of Ubiquitin Ligases in Genomic StabilityR01GM081840 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI BODDY, MICHAEL N · 2009 to 2018
$3.0M
NIGMS NIH HHS R01 GM068608NIGMS NIH HHS R01 GM081840
6 · The paper itself

Abstract

Posttranslational modifications (PTMs) provide dynamic regulation of the cellular proteome, which is critical for both normal cell growth and for orchestrating rapid responses to environmental stresses, e.g. genotoxins. Key PTMs include ubiquitin, the Small Ubiquitin-like MOdifier SUMO, and phosphorylation. Recently, SUMO-targeted ubiquitin ligases (STUbLs) were found to integrate signaling through the SUMO and ubiquitin pathways. In general, STUbLs are recruited to target proteins decorated with poly-SUMO chains to ubiquitinate them and drive either their extraction from protein complexes, and/or their degradation at the proteasome. In fission yeast, reducing or preventing the formation of SUMO chains can circumvent the essential and DNA damage response functions of STUbL. This result indicates that whilst some STUbL "targets" have been identified, the crucial function of STUbL is to antagonize SUMO chain formation. Herein, by screening for additional STUbL suppressors, we reveal crosstalk between the serine/threonine phosphatase PP2A-Pab1B55 and the SUMO pathway. A hypomorphic Pab1B55 mutant not only suppresses STUbL dysfunction, but also mitigates the phenotypes associated with deletion of the SUMO protease Ulp2, or mutation of the STUbL cofactor Rad60. Together, our results reveal a novel role for PP2A-Pab1B55 in modulating SUMO pathway output, acting in parallel to known critical regulators of SUMOylation homeostasis. Given the broad evolutionary functional conservation of the PP2A and SUMO pathways, our results could be relevant to the ongoing attempts to therapeutically target these factors.

Indexed as

Cell CycleCell ProliferationChromosomal Proteins, Non-HistoneDNA DamageDNA RepairGene DeletionGene DosageGenome, FungalGenotypeGreen Fluorescent ProteinsMutationPhenotypePoly(A)-Binding ProteinsProteasome Endopeptidase ComplexProtein Phosphatase 2Protein Processing, Post-TranslationalChromosomal Proteins, Non-HistoneGreen Fluorescent ProteinsPab1 protein, S pombePoly(A)-Binding ProteinsProteasome Endopeptidase ComplexProtein Phosphatase 2Rad60 protein, S pomberazor 1-1 protein, S pombeSchizosaccharomyces pombe ProteinsSlx8 protein, S pombeSmall Ubiquitin-Related Modifier ProteinsUbiquitin-Protein Ligases

Identifiers

PMID27398807
PMCPMC4939958
OpenAlexW2468185162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.